A detailed history of Inscription Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Inscription Capital, LLC holds 1,267 shares of AMGN stock, worth $373,169. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,267
Previous 1,240 2.18%
Holding current value
$373,169
Previous $387,000 5.43%
% of portfolio
0.06%
Previous 0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$309.38 - $337.38 $8,353 - $9,109
27 Added 2.18%
1,267 $408,000
Q2 2024

Jul 17, 2024

BUY
$262.75 - $319.31 $3,941 - $4,789
15 Added 1.22%
1,240 $387,000
Q1 2024

Apr 10, 2024

BUY
$268.87 - $324.56 $329,365 - $397,586
1,225 New
1,225 $348,000
Q2 2023

Jul 14, 2023

SELL
$214.27 - $253.37 $55,281 - $65,369
-258 Reduced 4.62%
5,327 $1.18 Million
Q1 2023

May 02, 2023

BUY
$225.79 - $275.2 $6,322 - $7,705
28 Added 0.5%
5,585 $1.35 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $81,763 - $103,890
-357 Reduced 6.04%
5,557 $1.46 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $322,324 - $363,523
-1,436 Reduced 19.54%
5,914 $1.33 Million
Q2 2022

Sep 20, 2022

BUY
$230.71 - $256.74 $184,798 - $205,648
801 Added 12.23%
7,350 $1.79 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $271,456 - $300,301
-1,238 Reduced 15.9%
6,549 $1.58 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $152,143 - $174,114
765 Added 10.89%
7,787 $1.75 Million
Q3 2021

Nov 09, 2021

SELL
$212.27 - $248.7 $13.2 Million - $15.4 Million
-61,954 Reduced 89.82%
7,022 $1.49 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $14.3 Million - $15.9 Million
61,389 Added 809.13%
68,976 $16.8 Million
Q1 2021

May 18, 2021

SELL
$221.91 - $258.6 $171,980 - $200,415
-775 Reduced 9.27%
7,587 $1.89 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $73,785 - $87,865
-341 Reduced 3.92%
8,362 $1.92 Million
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $92,686 - $103,075
-395 Reduced 4.34%
8,703 $2.21 Million
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $65,475 - $80,346
331 Added 3.78%
9,098 $2.15 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $82,190 - $109,006
-451 Reduced 4.89%
8,767 $1.78 Million
Q4 2019

Feb 04, 2020

BUY
$189.21 - $243.2 $310,682 - $399,334
1,642 Added 21.67%
9,218 $2.22 Million
Q3 2019

Nov 01, 2019

BUY
$174.11 - $208.62 $1.32 Million - $1.58 Million
7,576 New
7,576 $1.47 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.